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Summary
The P53 homolog p63 encodes multiple proteins with transactivating, apoptosis-inducing, and oncogenic activities. We
showed that p63 is amplified and that Np63 isotypes are overexpressed in squamous cell carcinoma (SCC) and enhance
oncogenic growth in vitro and in vivo. Moreover, p53 associated with Np63 and mediated its degradation. Here, we
report that Np63 associates with the B56 regulatory subunit of protein phosphatase 2A (PP2A) and glycogen synthase
kinase 3 (GSK3), leading to a dramatic inhibition of PP2A-mediated GSK3 reactivation. The inhibitory effect of Np63
on GSK3mediates a decrease in phosphorylation levels of-catenin, which induces intranuclear accumulation of-catenin
and activates -catenin-dependent transcription. Our results suggest that Np63 isotypes act as positive regulators of
the -catenin signaling pathway, providing a basis for their oncogenic properties.
Introduction GSK3 and also contributes to -catenin destruction (Kikuchi
et al., 2000; Janssens and Goris, 2001). PP2A consists of a
catalytic (C) subunit, a structural (A) subunit, and a variableWnt signal transduction pathways represent a very complex
signaling network, which actively contributes to the control of regulatory (B) subunit (Janssens and Goris, 2001). B56 regula-
tory subunits (, , , , and ) were shown to interact with APCcell proliferation during development and tumorigenesis (Barker
and Clevers, 2000; Polakis, 2000; Taipale and Beachy, 2001). and direct PP2A to dephosphorylate GSK3, leading to the
activation of GSK3 and subsequent degradation of -cateninOne target of the Wnt signaling cascade is -catenin, which
plays an important role in many human cancers. The association (McCright et al., 1996; McCright and Virshup, 1998; Seeling et
al., 1999; Li et al., 2001a). The overexpression of B56 ledof Wnt ligands with their cell surface receptors triggers the
activation of numerous downstream signaling events, which to activation of GSK3 by PP2A-mediated dephosphorylation,
which dramatically reduced the level of -catenin and inhibitedabolish the phosphorylation and ubiquitin-mediated degrada-
tion of -catenin, leading to the intranuclear accumulation of Lef-mediated gene transactivation (Seeling et al., 1999; Li et
al., 2001a).-catenin. -catenin associates with the T cell factor (Tcf)/lym-
phocyte enhancer binding factor (Lef) complex and mediates The -catenin nuclear accumulation is a critical event in
many cancers. Retroviral insertion of Wnt-expressing constructsthe regulation of Tcf/Lef-responsive genes that result in cell
proliferation and dedifferentiation (He et al., 1998; Barker and in the mammary gland dramatically induces accumulation of
-catenin and promotes tumor formation in mice (reviewed inClevers, 2000).
In the absence of Wnt, the association of -catenin with Li et al., 2001b). Transfection of murine cells with the Wnt con-
structs led to a tumorigenic phenotype and -catenin nuclearglycogen synthase kinase 3 (GSK3), Axin, and the adenoma-
tous polyposis coli (APC) protein leads to GSK3-mediated accumulation (Wong et al., 1994; Bafico et al., 1998). In humans,
mutations in the APC gene that produce a truncated polypeptidephosphorylation and targeting of -catenin into a proteasome
degradation pathway (Frame and Cohen, 2001; Janssens and unable to promote degradation of -catenin are abundant in
sporadic colon cancers (Morin et al., 1997). Point mutations inGoris, 2001). Protein phosphatase 2A (PP2A) is a serine-threo-
nine protein phosphatase associated with APC, Axin, and -catenin that alter N-terminal putative GSK3 phosphorylation
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Unlike p53, its homolog p63 is rarely mutated in cancers. P63 encodes multiple proteins with transactivating, apoptosis-inducing,
and oncogenic activities. In this report, we show that Np63 dramatically induces intranuclear accumulation of -catenin and
activates-catenin-responsive transcription. The mechanism underlying this novel function ofNp63 involves the physical association
of Np63 with B56, which inhibits phosphorylation of -catenin by GSK3 and its degradation. In squamous cell carcinomas (SCC),
mutations of the APC complex are virtually absent; however, SCC cells commonly harbor p53 mutations accompanied by p63 gene
amplification and/or overexpression ofNp63 isotypes. Thus, our observations support the oncogenic function ofNp63 and elucidate
molecular events leading to neoplastic progression in SCC.
CANCER CELL : MAY 2002 · VOL. 1 · COPYRIGHT  2002 CELL PRESS 369
A R T I C L E
sites have been found in colon, prostate, and skin cancers and data (Figure 1B, Table 1). In addition, GSK3 also forms com-
plexes with p40 when the latter is expressed together with B56in medulloblastomas and hepatocellular carcinomas (Rubinfeld
et al., 1997; Sparks et al., 1998; Zurawel et al., 1998; Voeller et (Figure 1B). Ectopically expressed Np63 was also shown to
bind B56, while TAp63 failed to associate with B56 in theseal., 1998; de La Coste et al., 1998; Chan et al., 1999). Mutations
in the N-terminal region of -catenin abrogate the phosphoryla- conditions (Figure 1C, central panel, lanes 3 and 4). Used as a
negative control, nonrelevant HA-tagged PTN (pleiotrophin) didtion of -catenin and, subsequently, its degradation. Axin muta-
tions have also been found in hepatocellular carcinomas and not associate with any p63 isotypes (Figure 1C, lower panel,
lanes 3 and 4). The HNSCC cell line 013 expressed variedother tumor types that lack APC or -catenin mutations (Satoh
et al., 2000; Dahmen et al., 2001). amounts of Np63, B56, GSK3, PP2A(C), APC, and Axin
(Figure 1D, lane 1). By coprecipitation, we showed a physicalPositive (oncogenic) and negative (tumor suppressive) regu-
lators of Wnt signaling have opposite effects on cell proliferation association between endogenous Np63 and B56 (Figure
1D, lane 2). Moreover, we demonstrated that GSK3 is alsoand tumorigenesis (Barker and Clevers, 2000; Polakis, 2000;
Taipale and Beachy, 2001). In contrast to adenocarcinomas, part of the Np63/B56 complex (Figure 1D, lane 2). However,
APC, Axin, and PP2A(C) were not detected in the Np63 pre-genetic changes in the components of Wnt signaling have not
been identified in human squamous cell carcinomas (SCC) from cipitates (Figure 1D, lane 2).
We wondered whether -catenin could be part of the Np63the lung, head and neck, skin, and cervix. Recently, we reported
increased expression of Np63 isotypes and amplification of complex. We had evidence that the carboxy terminus of p63
(including the sterile motif) binds -catenin itself in yeast (datap63 in these types of human cancers, which suggests that
Np63 isotypes play the role of putative oncoproteins (Hibi et not shown). Coprecipitation studies using HNSCC 013 cells
confirmed that Np63 binds to -catenin in the nucleus (Figureal., 2000). Moreover, the overexpression of Np63 isotypes in
transfected cells mediated an increase in tumor growth rates 2). In addition, -catenin and Np63 were found to colocalize
within intranuclear formations of 013 cells, further strengtheningin vitro and in vivo (Hibi et al., 2000). Overexpression of Np63
isotypes was also described in many other types of epithelial the notion that Np63 is an important component of -catenin
regulation.tumors (Parsa et al., 1999; Crook et al., 2000; Nylander et al.,
2000; Park et al., 2000). We next examined whether the overexpression of Np63
affects the protein level of -catenin. Our initial experimentsTo further understand the oncogenic properties of Np63
isotypes, we identified additional p63 protein binding partners, failed to show any effect of p63 isotypes on the RNA level of
-catenin (data not shown). We transfected HEK-293 cells withknown to function as key signaling intermediates that regulate
-catenin degradation. As described below, our results support expression constructs for TAp63, Np63, and deletion mu-
tants Np63-20 and Np63-41, lacking the first 20 or 41the notion that Np63 isotypes activate -catenin signaling and
elucidate a molecular mechanism that underlies the oncogenic residues, respectively. The latter constructs were generated
based on results of the two-hybrid screens, which demonstratedfunction of Np63 proteins in human squamous epithelial tu-
mors. that residues 1–20 are necessary to mediate binding of Np63
to B56 (Table 1). As negative and positive controls, we used
HEK-293 cells grown in the presence of either the conditionedResults
medium (CM) from uninfected mammary epithelial cells or CM
from C57MG-MV-Wnt-1 mammary epithelial cells that secreteTo better understand the role of p63 in cell proliferation and
tumorigenesis, we applied a yeast two-hybrid screen to identify the physiologically active Wnt-1, respectively (Bradley and
Brown, 1995). As shown, the extracellular Wnt ligand mediatespossible p63-interacting proteins. In addition to p53 (Ratovitski
et al., 2001), we identified B56, the regulatory subunit of PP2A, an increase in -catenin protein levels (Figure 3A, lanes 1 and
2). We also observed that ectopic expression of Np63 (Figureas a p63-interacting candidate.
To examine the regions required for the association of B56 3A, lane 6) led to dramatic accumulation of -catenin. However,
Np63-41, Np63-20, and TAp63 failed to increase thewith p63, we generated truncated variants of B56 and the p63
core domain (p40). Truncated fragments of p40 or B56 were protein levels of -catenin (Figure 3A, lanes 3, 4, and 5, respec-
tively). Thus, these data strongly suggest that residues 1–20fused to the Gal4 binding domain or the Gal4-activation domain,
respectively. Using the two-hybrid assay, we found that the are critical for the interaction between Np63 and B56 and
for the Np63-induced -catenin accumulation (Figure 3A).protein domain of PP2A-B56 (residues 76–150) is necessary
to mediate the interaction with p63. Likewise, the N-terminal We further examined whether Np63 overexpression af-
fects the subcellular localization of -catenin. We used HEK-domain of p40 (residues 1–20) mediates the association with
B56 (Figure 1A, Table 1). 293 cells transfected with an empty pCEP4 vector (Np63)
or with the pCEP4-Np63 expression construct (Np63)To further confirm these observations, we analyzed the inter-
action of B56 and p40 ectopically expressed in Saos-2 cells as a source of nuclear and cytoplasmic fractions. The purity of
nuclei and the cytoplasm was confirmed by immunoblotting(Figure 1B) using coprecipitation assays. We also transfected
Saos-2 cells with plasmids harboring Np63, TAp63, and with antibodies to specific markers as indicated (Figure 3B). As
shown, overexpression of Np63 dramatically increased theGSK to evaluate the association between these proteins. Com-
plexes between p63 isotypes and B56 were precipitated from intranuclear protein level of -catenin. Interestingly, the protein
levels of both B56 and GSK3 also rise in the nuclei (Figuretotal lysates with an antibody recognizing the DNA binding do-
main of p63 proteins (4A4), followed by immunoblotting with an 3B). Conversely, we observed that APC, Axin, and PP2A(C)
are predominantly located in the cytoplasm in the presence orantibody to B56 (Figure 1B). A significant amount of B56
could be coprecipitated from extracts containing p40, but not absence of Np63 expression (data not shown).
The nuclear accumulation of Np63 associated with B56,in extracts lacking p40, confirming the yeast two-hybrid screen
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Figure 1. Np63 isotypes physically associate
with B56
A: A schematic representation of p63 isotypes
(p40 and Np63 versus TAp63); the N-terminal
domain of Np63 isotypes is thought to mediate
binding to B56. B: Interaction of Np63 isotypes
with the B56 subunit of PP2A. Saos-2 cells were
transfected (50% efficiency) with various plas-
mids (2 	g each): pCEP4-HA-B56, pCEP4-FLAG-
GSK3, pCEP4-p40, pCEP4-TAp63, or pCEP4-
HA-PTN. Total lysates expressing ectopic B56
(lanes 1–3 and 5), GSK3 (lanes 2–4), and p40
(lanes 3–5) were used. Protein levels were de-
tected by immunoblotting (30 	g of cell lysate)
with antibodies to B56 (upper panel), GSK3
(central panel), or Np63 (lower panel). P63
complexes were immunoprecipitated (IP, 100
	g cell lysate) using antibody to p63 (4A4), fol-
lowed by immunobloting with antibodies to B56
(upper panel) or GSK3 (lower panel). C: Total
lysates expressing TAp63 (lanes 1 and 4) or
Np63 (lanes 2 and 3) were analyzed by immu-
noblotting (lanes 1 and 2, 40 	g cell lysate)
with antibodies to p63 (4A4, upper panel), B56
(central panel), or HA (lower panel) or were im-
munoprecipitated (IP, 120 	g) with antibody
4A4 (lanes 3 and 4), followed by immunoblotting
with indicated antibodies. D: Endogenous B56/
GSK3/Np63 complexes in HNSCC 013 cells.
Total lysates from HNSCC 013 cells were assayed
for expression of B56, GSK3, Np63, PP2A(C),
APC, and Axin (lane 1) by immunoblotting (50
	g). Np63 complexes were immunoprecipi-
tated (IP, 150 	g cell lysate) with antibody to
Np63 and were immunoblotted with antibodies
to B56, GSK3, Np63, PP2A(C), APC, and Axin
(lane 2). Endogenous Np63 forms complexes
with B56 and GSK3, but does not associate
with APC, Axin, or PP2A(C). Moreover, TAp63
does not interact with B56.
GSK3, and -catenin suggests its positive role in -catenin pressing endogenous Np63) with an empty Ad5 or Ad-
Np63-AS adenovirus. Our data clearly show that overexpres-signaling and oncogenic growth. This observation led us to
explore a correlation between the intranuclear levels of Np63 sion of Np63-AS decreases levels of both Np63 and
-catenin (Figure 5A, top and central panels, respectively). Tak-(p40) and -catenin in mouse tumor xenografts. The xenografts
were initially obtained by injection of Rat1 cells transfected ing into consideration that a decrease in Np63 might cause
apoptotic changes, we examined the protein levels of -actinwith pCEP-p40 expression construct versus an empty pCEP4
vector (Hibi et al., 2000). We previously reported that transfec- and found no change (Figure 5A, lower panels). Furthermore,
transfection of these cells with pCEP4-Np63-AS (versus cellstion of Rat1 cells with pCEP-p40 led to a dramatic increase
in tumorigenic foci formation and, in turn, to a greater growth transfected with an empty vector) modulated the proliferation
rate of both HNSCC 012 (wild-type p53, curve 3 versus curveof tumors in athymic nude mice (Hibi et al., 2000). We found
that these tumor xenografts exhibiting increased growth (Hibi 1) and 013 (mutated p53, curve 4 versus curve 2) cells, support-
ing a critical role for Np63 in the regulation of cell proliferationet al., 2000) due to p40 overexpression also demonstrated abun-
dant intranuclear accumulation of -catenin (Figure 4A). The (Figure 5B).
To determine whether the increase in the -catenin intra-intranuclear levels of -catenin also correlated with those of
Np63 in isogenic HNSCC cell lines 012 and 013 (Figure 4B). nuclear accumulation induced by Np63 leads to an increase
in the -catenin-mediated activation of transcription, we trans-013 cells harbor mutated p53, leading to an increase of intra-
nuclear Np63 and -catenin levels (Figure 4B), and higher fected HEK-293 cells (which contain intact -catenin signaling
machinery) with expression plasmids (indicated in the legendrates of cell proliferation than isogenic 012 cells (see below).
Thus, the increased nuclear accumulation of -catenin corre- of Figure 5C) and analyzed their effect on the Lef-1: luciferase
reporter activity. As shown, expression of B56 reduced lucifer-lates with the oncogenic potential of Np63.
To further evaluate the effect of Np63 on the nuclear ase activity by 50%, while expression of Np63 activated
luciferase activity by 3- to 4-fold (Figure 5C, samples 2 and 3accumulation of -catenin, we infected HNSCC 013 cells (ex-
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Table 1. P63 core domain (p40) interacts with B56 in a yeast genetic assay
-galactosidase
No Bait Prey Trp- Leu- His- (nmole/min/mg)
1. pGal4-BD-p53WT pGal4-AD-SV-40    61.8 
 5.9
2. pGal4-BD-lamin C pGal4-AD-SV-40   -- 2.1 
 0.5
3. pGal4-BD-p40 (1–356) pGal4-AD   -- 2.9 
 0.9
4. pGal4-BD pGal4-AD-B56 (1–408)   -- 3.6 
 0.7
5. pGal4-BD-p40 (1–356) pGal4-AD-B56 (1–408)    39.1 
 4.1
6. pGal4-BD-p40 (1–74) pGal4-AD-B56 (1–408)    38.8 
 3.4
7. pGal4-BD-p40 (75–266) pGal4-AD-B56 (1–408)   -- 6.7 
 2.5
8. pGal4-BD-p40 (267–356) pGal4-AD-B56 (1–408)   -- 3.7 
 0.9
9. pGal4-BD-p40 (1–356) pGal4-AD-B56 (1–75)   -- 6.5 
 2.4
10. pGal4-BD-p40 (1–356) pGal4-AD-B56 (1–150)    38.5 
 3.6
11. pGal4-BD-p40 (1–356) pGal4-AD-B56 (1–225)    38.8 
 3.7
12. pGal4-BD-p40 (1–356) pGal4-AD-B56 (1–300)    38.6 
 3.4
13. pGal4-BD-p40 (1–356) pGal4-AD-B56 (1–408)    38.9 
 4.1
14. pGal4-BD-p40 (1–356) pGal4-AD-B56 (76–408)    38.5 
 3.6
15. pGal4-BD-p40 (1–356) pGal4-AD-B56 (150–408)   -- 5.8 
 1.7
16. pGal4-BD-p40 (1–356) pGal4-AD-B56 (225–408)   -- 5.6 
 1.4
17. pGal4-BD-p40 (1–356) pGal4-AD-B56 (300–408)   -- 5.9 
 1.1
18. pGal4-BD-p40 (21–356) pGal4-AD-B56 (1–408)   -- 5.4 
 1.6
19. pGal4-BD-p40 (42–356) pGal4-AD-B56 (1–408)   -- 5.1 
 1.3
Amino acid residues are in parentheses.
versus sample 1, respectively). In addition, an antisenseNp63 other plasmids (Figure 5C). We observed that expression of
B56 reduced the luciferase activity (by 30%–40%) inducedconstruct (Np63-AS) reduced luciferase activity mediated by
the endogenous -catenin/Lef-1 complex, while TAp63 had by ectopic -catenin, whereas Np63 expression dramatically
increased (by 8-fold) this activity (Figure 5C, samples 7 andno effect on this activity (Figure 5C, samples 4 and 5 versus
sample 1, respectively). We then transfected HEK-293 cells with 8 versus sample 6, respectively). However, Np63-AS (sample
9) counteracts the inducible effect of Np63, while TAp63pCEP4-myc-tagged FL--catenin and various combinations of
Figure 2. Association of Np63 and -catenin
A: The physical interaction of endogenous
Np63 and -catenin. Nuclear lysates (30 	g)
from HNSCC 013 cells were analyzed for protein
levels of Np63 and -catenin by immunoblot-
ting. Levels of DNA topoisomerase II (TOPO II)
served as a loading and fractionation control.
For immunoprecipation (IP) with the indicated
antibodies, 150 	g nuclear lysates was used.
B: Nuclear colocalization of Np63 and
-catenin. HNSCC 013 cells were stained with
antibody to -catenin (green) or antibody to
Np63 (red) and were counterstained with
DAPI for nuclear DNA (blue). Merging of the two
stainings shows colocalization of the two proteins
(Np63 and -catenin) in the nucleus (yellow).
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Figure 4. Endogenous Np63 increases the intranuclear levels of -catenin
in tumor xenografts and HNSCC cell lines
A: Tumor xenografts were obtained from nude mice injected with Rat1
cells transfected with the control vector pCEP4 (lanes 1–3) or with pCEP4-
p40 (lanes 4–7). Nuclear proteins (40 	g) were analyzed by immunoblot-
ting with antibodies to Np63 (upper panel) or -catenin (central panel).
B: Nuclear proteins from isogenic HNSCC cell lines 012 and 013 were ana-
Figure 3. Np63 inhibits degradation of -catenin and induces its intra- lyzed by immunoblotting with antibodies to Np63 (upper panel) or
nuclear accumulation -catenin (central panel). Loading levels were examined by immunoblot-
ting with antibody to DNA topoisomerase II. Np63 (p40) overexpressionA: HEK-293 cells were grown in the presence of conditioned medium (CM)
correlates with an increase in the intranuclear levels of -catenin in tumorwith Wnt-1 or control CM (lanes 1 and 2) or were transfected (70% effi-
xenografts and HNSCC cell lines.ciency) with 2 	g TAp63, Np63 (lanes 5 and 6), or Np63-41 or
Np63-20 expression constructs (lanes 3 and 4). Total lysates (40 	g)
were resolved by 10% SDS-PAGE and were immunoblotted with antibodies
to p63 (4A4, upper panel) or -catenin (central panel). Loading levels were
examined by immunoblotting with antibody to -actin (lower panel). B: To examine the molecular mechanism of Np63-induced
Nuclear and cytoplasmic fractions were isolated from HEK-293 cells trans-
-catenin accumulation, we evaluated the effect of Np63fected (60% efficiency) with 2 	g empty pCEP4 vector (Np63) or
on the phosphorylation of -catenin by GSK3. HEK-293 cellspCEP4-Np63 (Np63). Proteins obtained from nuclear (30 	g) and
cytoplasmic (50	g) fractions were resolved by SDS-PAGE and were immu- proven to maintain a putative APC destruction complex (Seeling
noblotted with antibodies to -catenin, Np63, B56, or GSK3. As loading et al., 1999), and tested for the presence of the components of
and fractionation controls, we used antibodies to DNA topoisomerase II
the APC complex and -TrCP (data not shown), were trans-(nuclei) or -tubulin (cytoplasm). Np63 increases the protein level of
fected with plasmids: (i) pCEP4-FLAG-GSK3 and pCEP4-myc--catenin, while the expression of TAp63, Np63-20, or Np63-41 had
no effect on -catenin levels. Np63dramatically induces the intranuclear FL--catenin, (ii) pCEP4-GSK3, pCEP4-HA-B56, and
abundance of -catenin, while B56 and GSK3 also undergo nuclear ac- pCEP4-myc-FL--catenin, (iii) pCEP4-FLAG-GSK3, pCEP4-
cumulation. Np63, and pCEP4-myc-FL--catenin, (iv) pCEP4-FLAG-
GSK3, pCEP4-HA-B56, pCEP4-Np63, and pCEP4-myc-
FL--catenin. As a control, we used HEK-293 cells transfected
with an empty pCEP4 vector. In addition to endogenous GSK3,(sample 10) and deletion mutants of Np63 (Np63-20,
ectopic expression of GSK3 greatly induced phosphorylationNp63-41, and Np63-74) failed to activate the luciferase
of -catenin (by 3-fold, Figure 6A, lane 2 versus lane 1), whileactivity (Figure 5C, samples 11–13). Thus, these results strongly
the coexpression of B56 increased the phosphorylation levelsupport the notion that overexpression of Np63 causes in-
of -catenin by 60% (Figure 6A, lane 3 versus lane 2). How-creased activation of transcription at -catenin-dependent pro-
moters. ever, when Np63 was coexpressed with B56, it led to a
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dramatic inhibition of GSK3-mediated phosphorylation of
-catenin by 8-fold (Figure 6A, lane 5 versus lane 2) and,
therefore, to an accumulation of total -catenin (Figure 6A).
Interestingly, the addition of Np63 alone to GSK3 and
-catenin had a slight inhibitory effect on the phosphorylation
level of -catenin (15%, Figure 6A, lane 4 versus lane 2),
suggesting that ectopic Np63may titrate down some endog-
enous PP2A regulatory proteins present in HEK-293 cells. Con-
versely, even Np63 in the presence of B56 failed to induce
accumulation of N90--catenin, which lacks the residues nor-
mally phosphorylated by GSK3 (Figure 6A).
To further evaluate whether Np63 affects GSK3 kinase
activity, we transfected HEK-293 cells with individual plasmids:
(i) an empty pCEP4 vector, (ii) GSK3, (iii) B56, (iv) Np63,
and (v) -catenin. Total lysates were mixed in various combina-
tions and were preincubated for 30 min at 4C, then complexes
were immunoprecipitated with antibody to GSK3, and the
bead-bound proteins were incubated with [32P]ATP and a pre-
phosphorylated synthetic peptide (YRRAVPPSPSLSRHSSPH
QSEDEE), as a substrate for GSK3, as described (Ikeda et al.,
1998). We observed (Figure 6B) that the addition of B56 (sam-
ple 3 versus sample 2) activated GSK3 kinase activity (by
50%), while Np63 alone (sample 4 versus sample 2) had
little inhibitory effect on GSK3 activity (10%). However, the
addition of both B56 andNp63dramatically reduced GSK3
activity by 40% compared to samples containing ectopic
GSK3 alone (sample 5 versus sample 2) and reduced activity
4-fold less than a mix of GSK3 and B56 (sample 5 versus
sample 3).
Immunoblotting analysis (Figure 6C) demonstrated that
phosphorylation levels of the GSK3 protein itself changed ac-
cordingly in the presence of various components: levels de-
creased in the presence of B56 (by 50%), slightly increased
in the presence of Np63 alone (10%), and greatly increased
in the presence of both B56 and Np63 (3-fold), while
Np63-AS successfully counteracted the effect of Np63
(Figure 6C).
Since the B56 regulatory subunit was reported to activate
PP2A, mediating GSK3 dephosphorylation and increasing its
Figure 5. Np63 induces -catenin-mediated transcription and cell prolifer- activity (Seeling et al., 1999), we examined whether the activa-
ation tion of -catenin by Np63 is due to the inhibitory effect of
A: The inhibitory effect of anti-sense Np63 on the protein levels of Np63 on GSK3 or to its effect on PP2A, which could directly
-catenin. HNSCC 013 cells (with endogenous Np63) were infected with
dephosphorylate-catenin.Np63 overexpression greatly de-variable amounts (MOI) of control Ad5 or Ad-Np63-AS as indicated (95%
efficiency). Total lysates (30 	g) were analyzed by immunoblotting with creased the phosphorylation levels of -catenin in the presence
antibodies toNp63 (top panels) or -catenin (central panels). Protein levels of NaCl (5-fold, Figure 7A, lane 2 versus lane 1) and withoutof -actin served as loading controls (bottom panels). B: The expression of
OA (okadaic acid) (5-fold, Figure 7A, lane 4 versus lane 3),Np63-AS cell proliferation. HNSCC 012 (curves 1 and 3) or 013 (curves 2
and 4) cells were transfected (80% efficiency) with 5 	g empty pCEP4 whereas inhibition of GSK3 with LiCl almost entirely inhibits
vector (curves 3 and 4) or pCEP4-Np63-AS expression construct (curves
-catenin phosphorylation regardless of Np63 levels (Figure1 and 2). Cell growth was assayed with the MTS/PMS nonradioactive kit
7A, lane 6 versus lane 5). Inhibition of PP2A with OA negligibly(Promega), and cell density was followed for the times indicated. C:Np63
dramatically increases the -catenin-mediated induction of Lef-1: lucifer- affects the phosphorylation levels of -catenin similarly in both
ase reporter activity. HEK-293 cells were transfected with the Lef-1: luciferase
conditions (Figure 7A, lane 8 versus lane 7). The phosphorylationreporter (or mutant Lef-1: luciferase reporter) plasmid. All transfections in-
cluded a CMV:-galactosidase construct to control for transfection effi- levels of -catenin inversely correlate with -catenin protein
ciency. Lef-1-dependent activity was defined as the ratio of activity from levels (Figure 7A). Regarding phospho-GSK3, we observed
the wild-type Lef-1: luciferase reporter plasmid divided by luciferase activity
that Np63 increases the phosphorylation levels of GSK3 infrom the mutant Lef-1: luciferase reporter plasmid. This value was normalized
to Lef-1: luciferase activity obtained from control cells transfected with an the presence of NaCl or LiCl and in the absence of OA (4- to
empty pCEP4 vector (Sample 1). Luciferase activity was determined with 6-fold, Figure 7A, lanes 2, 4, and 6 versus lanes 1, 3, and 5,luciferase reagent (Promega), and -galactosidase was assayed using the
respectively), while inhibition of PP2A (OA) led to a slight butGALACTON reagent (Tropix). Cells were cotransfected with various plasmids
(Samples: 2, pCEP4-HA-B56; 3, pCEP4-Np63; 4, pCEP4-Np63-AS; 5, equal increase of phospho-GSK3 under both conditions
TAp63; 6, pCEP4-myc-tagged FL--catenin; 7, pCEP4-HA-B56; 8, pCEP4- (25%, Figure 7A, lane 8 versus lane 7). To directly test theNp63; 9, pCEP4-Np63-AS; 10, pCEP4-TAp63; 11, pCEP4-Np63-20;
12, pCEP4-Np63-41; 13, pCEP4-Np63-74). All reporter assays were effect ofNp63 on PP2A activity, we performed a phosphatase
performed in triplicate (mean  SD is shown). assay on HEK-293 cell lysates without or with Np63. Our
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Figure 7. Np63 inhibits phosphorylation of -catenin through modulation
of GSK3 reactivation
A: HEK-293 cells were transfected (2 	g each, 70% efficiency) with anFigure 6. Np63 inhibits GSK-mediated phosphorylation of -catenin
empty pCEP4 vector (lanes 1, 3, 5, and 7) or pCEP4-Np63 (lanes 2, 4, 6,A: HEK-293 cells were transfected (75% efficiency) with plasmids (2 	g of
and 8) and were treated overnight with 30 mM NaCl or 30 mM LiCl (aneach): (i) -catenin (FL), (ii) GSK3 and -catenin, (iii) GSK3, B56, and
inhibitor of GSK3) or with 20 nM okadaic acid (OA, an inhibitor of PP2A).-catenin, (iv) GSK3,Np63, and -catenin, and (v) GSK3, B56,Np63,
Total lysates (50 	g) were resolved by 7.5% SDS-PAGE and were immu-and -catenin. Total lysates (50 	g) were resolved by 7.5% SDS-PAGE,
noblotted with the antibodies indicated. Np63 increased GSK3 phos-followed by immunoblotting with the indicated antibodies. In some experi-
phorylation levels and conversely decreased -catenin phosphorylationments, cells were transfected (instead of -catenin [FL]) with the pCEP-
levels. However, inhibitor of PP2A negligibly affects these levels. B: Np63N90--catenin construct, which encodes a truncated -catenin lacking
inhibits PP2A activity in vitro. Immunoprecipitates of PP2A (200 	g totalthe N-terminal region. Protein levels of -actin served as loading controls.
lysate) from HEK-293 cells transfected with an empty pCEP4 vector or pCEP4-B: Np63 inhibits GSK kinase activity in vitro. Samples: HEK-293 cells were
Np63 were analyzed for phosphatase activity as described. Np63 in-transfected (75% efficiency) with individual plasmids (2 	g of each): (i)
hibits -catenin phosphorylation via PP2A-dependent inhibition of GSK3empty pCEP4, (ii) GSK3, (iii) B56, (iv) Np63, and (v) -catenin. Total
rather than by activating PP2A to directly dephosphorylate -catenin.lysates were prepared and mixed for 30 min at 4C in various combinations
as follows: (1) empty pCEP4; (2) pCEP4 plus GSK3; (3) pCEP4 plus GSK3
and B56; (4) pCEP4 plus GSK3 and Np63; and (5) pCEP4 plus GSK3,
B56, and Np63. GSK3 immunoprecipitates (200 	g total lysates) were
assayed for kinase activity in triplicate. C: Np63 inhibits the PP2A-medi- results clearly show an inhibitory effect of Np63 on PP2A
ated dephosphorylation of GSK3. Saos-2 cells were transfected (70% activity in vitro (Figure 7B).
efficiency) with the following plasmids (1	g each): (1) GSK3and -catenin,
(2) B56, GSK3, and -catenin, (3) Np63, GSK3, and -catenin, (4)
DiscussionGSK3, -catenin, B56, and Np63, or (5) GSK3, -catenin, B56, 1 	g
Np63, and 5 	g Np63-AS. Immunoblotting of total lysates with the
phospho-GSK3 (Ser9) antibody shows that the B56 regulatory subunit of Recent reports show that Np63 is the most abundantly ex-
PP2A mediates dephosphorylation of GSK3, whileNp63 (in the presence pressed isotype in tumor cells, and it has been implicated inof B56) inhibits this process.
cell proliferation and oncogenic growth (Hibi et al., 2000; Parsa
et al., 1999; Crook et al., 2000; Nylander et al., 2000; Park et
al., 2000). The studies of p63 null mice further substantiate a
critical role for p63 in regulating cell proliferation and in mediat-
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ing epidermal stem cell renewal during early development (Yang structural overlap (Thomas and Tyers, 2000). Therefore, the TA
domain is likely to play a dual role in transcriptional activationet al., 1999; Mills et al., 1999). These findings raise the intriguing
possibility that p63 functions as a regulator of cell growth in and subsequently its own destruction (Salghetti et al., 2001).
These and other features may account for the high abun-normal tissues and in cancer. Our studies now strongly suggest
that Np63 isotypes function as positive regulators of -catenin dance of the Np63 isotype in human cancer cells (Parsa et
al., 1999; Crook et al., 2000; Nylander et al., 2000; Park et al.,signaling.
We have presented data demonstrating a physical interac- 2000).
The intriguing association between p63 and B56 furthertion between Np63 and B56, GSK3, and -catenin. This
association was initially shown for p40 (p63 core domain) and emphasizes the role of these two proteins in both embryogene-
sis and the regulation of cell proliferation in adult tissues. BothB56 in yeast by coimmunoprecipitation of the ectopically ex-
pressed p40 and B56 proteins and endogenous Np63, embryogenesis and tumorigenesis rely on cell communication
via the Wnt signaling pathway, resulting in the presence orB56, GSK3, and -catenin.
The B56 regulatory subunit associates with the N terminus absence of the intranuclear-catenin (Barker and Clevers, 2000;
Polakis, 2000; Taipale and Beachy, 2001). In the absence ofof APC and, therefore, recruits the PP2A heteromeric enzyme
to the APC complex consisting of APC, Axin, GSK3, -catenin, the Wnt ligand, a multiprotein complex containing APC, GSK3,
and Axin normally facilitates the addition of phosphate groupsand other accessory elements (Seeling et al., 1999; Kikuchi,
2000; van Es et al., 2001). Moreover, B56 was shown to nega- to -catenin by GSK3, which, in turn, results in the ubiquitina-
tion of -catenin and its proteasome-dependent degradationtively regulate -catenin signaling by tethering PP2A to GSK3
and thereby inducing the ability of GSK3 to phosphorylate (Ikeda et al., 1998, 2000). Activation of the Wnt pathway results
in disassembly of the APC-Axin complex and leads to inhibition-catenin and target -catenin into a proteasome degradation
pathway (Seeling et al., 1999; Li et al. 2001a). The association of -catenin degradation by decreasing the ability of GSK3 to
phosphorylate -catenin (Barker and Clevers, 2000; Polakis,of Np63 with B56 prompted us to investigate the molecular
mechanisms underlying the effect of p63 on -catenin degrada- 2000). This reduces -catenin susceptibility to degradation,
leading to its intranuclear accumulation. We have shown antion mediated by B56. We observed that overexpression of
the Np63 isotypes (p40 or Np63) dramatically increases inhibitory effect of Np63 on GSK3 kinase activity. Moreover,
Np63 decreases the phosphorylation level and increases thethe intranuclear accumulation of -catenin. Moreover, Np63
coprecipitated with B56 and GSK3 in the nuclei, while APC nuclear abundance of -catenin. In adenocarcinomas (e.g., co-
lon cancers), the oncogenic mutations in genes encoding vari-and Axin retained their cytoplasmic location. In addition, the
ectopic expression of Np63 led to inhibition of the ous components of the Wnt pathway (APC and Axin) and muta-
tions of phosphorylation sites in -catenin are common andGSK3-mediated phosphorylation of -catenin, apparently by
directly affecting the ability of B56 to reactivate GSK3 activity increase the stability of -catenin (Morin et al., 1997; Sparks et
al., 1998; de La Coste et al., 1998). In SCC (e.g., lung cancer),and, therefore, blocking the degradation of -catenin. Further-
more, the inhibitory effect of Np63 on GSK3 counteracts these mutations are virtually absent; however, SCC cells often
harbor p63 gene amplification and/or overexpression of Np63and modulates the activation of GSK3 by B56/PP2A, which
can be seen in the dramatic intranuclear accumulation and de- isotypes (Hibi et al., 2000). P40-overexpressing xenografts with
increased growth rates in vitro and in vivo (Hibi et al., 2000)creased phosphorylation levels of -catenin and increased
phosphorylation (and reduced activity) of GSK3 mediated by were shown here to harbor higher -catenin levels in nuclei
compared to control xenografts. Thus, the increase in Np63,Np63. Moreover, the association of Np63 with B56 and
-catenin targets B56, -catenin, and GSK3 into the nucleus, which induces intranuclear accumulation of -catenin, repre-
sents an alternative mechanism of -catenin signaling activationwhile leaving APC and Axin in the cytoplasm. Thus, Np63
isotypes appear to act as positive regulators of the -catenin that induces positive regulation of -catenin-responsive genes
in SCC.signaling pathway, perhaps by contributing to disassembly and
inactivation of the APC degradation complex. Interestingly, the aberrant intranuclear accumulation of
-catenin in tumors is often associated with mutational inactiva-Interestingly, TAp63 is not able to affect the protein level
of -catenin, despite sharing the same carboxyl terminus as tion of the p53 tumor suppressor. The overexpression of p53,
by either transfection or DNA damage, was recently shown toNp63. By comparative alignment of p40 and TAp63 isotypes,
we observed that some portions of the B56-interacting domain downregulate nuclear levels of -catenin in human and mouse
cells accompanied by inhibition of its transactivation potentialpresent in p40 are different compared to the TA isotypes (resi-
dues 1–6 and 8–12). Also, additional sequences (26 residues (Sadot et al., 2001). This effect was not obtained with transcrip-
tionally inactive mutant p53. The inhibitory effect of p53 onbetween 14 and 15) are present in TAp63 isotypes that are likely
to affect the 3D configuration of this critical domain. In contrast -catenin is apparently mediated by the ubiquitin-proteasome
system and requires an active GSK3. Mutations in -catenin,to Np63, TA isotypes contain the N-terminal TA domain,
which affects its stability and targets TAp63 into a proteasome which compromise its phosphorylation and therefore the degra-
dation by proteasomes or the inhibition of GSK3 activity, alldegradation pathway (Osada et al., 2001). Many transcription
factors are known to be unstable proteins that are destroyed rendered -catenin resistant to downregulation by p53. These
findings outline a negative-feedback loop involving -cateninby ubiquitin (Ub)-mediated proteolysis through the 26S protea-
some (Thomas and Tyers, 2000; Salghetti et al., 2000, 2001). and p53, in which excess -catenin induces the accumulation
of p53, while high p53 levels downregulate-catenin. In contrastRecently, it was shown that two distinct regions mediating tran-
scriptional activation (TA domain) or Ub-dependent degradation to p53, Np63 isotypes mediate intranuclear accumulation of
-catenin and, therefore, oppose the function of p53 as a tumor(“degron”) of several transcriptional factors (i.e., p53; TA do-
main, residues 13–52; degron, residues 1–40) demonstrate suppressor and support the function of Np63 as an oncopro-
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inducible gene Siah-1 actively functions in the destruction of
-catenin and, therefore, in the downregulation of -catenin
signaling (Liu et al., 2001; Matsuzawa and Reed, 2001). Our
initial experiments failed to demonstrate that Np63 affects
the expression of Siah-1 (data not shown).
Other mechanisms may also underlie the oncogenic function
of Np63 isotypes and may contribute to tumorigenesis. For
example, Np63 proteins may function as dominant-negative
regulators of p53-mediated transactivation of specific genes
implicated in cell cycle control and apoptosis, as demonstrated
by in vitro luciferase reporter assays (Yang et al., 1998). How-
ever, many primary SCC harbor p53 mutations accompanied
by overexpression of Np63 (Hibi et al., 2000; Yamaguchi et
al., 2000). The common clonal expansion of cells that harbor
both p53 inactivation and p63 amplification suggests that
Np63’s oncogenic properties, as described here, extend be-
yond a dominant-negative effect on p53 function. The respective
contribution of each mechanism underlying p63 oncogenic
function in tumorigenesis remains to be fully explored.
Experimental procedures
Two-hybrid yeast expression screens
We screened the Hybri-Zap mouse embryonic cDNA library (B6: C57BL/6,
14.5, Stratagene) with the pGal4-BD-p40. Positive transformants were se-
lected on a medium lacking tryptophan, leucine, and histidine and were
identified by a -galactosidase filter lift assay and by the quantitative
-galactosidase liquid assay using o-nitrophenyl--D-galactopyranoside as
a substrate (Ratovitski et al., 2001).
Cells, antibodies, and plasmids
We used osteosarcoma cells (Saos-2), head and neck squamous cell carci-
noma cells (HNSCC, line 012 and 013), and human embryonic kidney (HEK)-
Figure 8. Opposing effects of p53 and Np63 on -catenin in normal and 293 cells. Saos-2 and HEK-293 cells were obtained from American Tissue
cancer cells Culture Collection and were maintained accordingly. HNSCC 012 and 013
A: In normal cells, p53 induction leads to direct degradation of Np63 cells were defined at the Johns Hopkins Medical Institutions, grown, and
(Ratovitski et al., 2001) and proposed activation of GSK3 (Sadot et al., harvested (at 60%–80% confluency) as described (Ratovitski et al., 2001).
2001), resulting in -catenin degradation. B: In SCC cancer cells, p53 muta- We used rabbit polyclonal antibodies to Np63 (Oncogene Research), to
tions commonly lead to the accumulation of Np63. Np63 binds to B56 phospho-(Ser33/37/Thr41)--catenin and phospho-(Ser9)-GSK3 (both
and alters its conformation, resulting in dramatic inhibition of GSK3 activity from Cell Signaling Technology/New England Biolabs), and to APC (C-20);
by modulating the PP2A-mediated reactivation of GSK3 and probably
goat polyclonal antibodies to Axin (R-20), to PP2A-B56 (C-18), to DNA
dismantling the APC complex. Thus, nonphosphorylated -catenin is aber-
topoisomerase II (designated as TOPO II, L-17), and to -TrCP/E3RS (C-rantly accumulated in the nucleus, which leads to activation of -catenin/
18) (all from Santa Cruz Biotechnology); monoclonal antibodies to p63 (4A4)Tcf/Lef-responsive genes, controlling tumor cell growth and contributing to
and -tubulin (TU-02) (from Santa Cruz Biotechnology); monoclonal antibod-the neoplastic phenotype. The organization of the APC complex is based
ies to -catenin and GSK3 (Transduction Laboratories) and hemagglutininon structural studies (Kikuchi, 2000; Spink et al., 2000; van Es et al., 2001).
(HA, 12CA5, Roche Molecular Biochemicals); and rabbit polyclonal antibody
to catalytic subunit (C) of PP2A (Upstate Biotechnology). We used mamma-
lian expression cassettes; pCEP4-HA-tagged B56, pCEP4-FLAG-tagged
GSK3, pCEP4-myc-tagged FL--catenin, and pCEP4-myc-tagged N90-
tein. The inhibition of p53-mediated degradation of -catenin -catenin (kindly provided by David M. Virshup), pCEP4-TAp63, pCEP4-
may further unleash the oncogenic activity of -catenin, thereby Np63, pCEP4-p40, in which the expression of desirable proteins was
contributing to tumor progression. This effect may occur driven by the cytomegalovirus (CMV) promoter. The full-length human Siah-1
cDNA was obtained from John C. Reed (through Science Reagents). Forthrough inactivation of the p53 gene (e.g., by mutation), leading
activation of Wnt signaling, we used CM from C57MG-MV-Wnt-1 mammaryto an increase in Np63-mediated intranuclear accumulation of
epithelial cells secreting Wnt-1 protein. This cell line infected with retroviral-catenin (Figure 8).
vector pMV-Wnt-1was kindly provided by Anthony M.C. Brown. To obtain
We thus propose a schematic model in which induction of CM from C57MG cells infected with MV-Wnt-1 or empty MV-7, cells were
p53 (Figure 8A) leads to p53-mediated degradation of Np63 plated at a density of 105 per 10-cm2 dish and were grown to confluence,
isotypes (Ratovitski et al., 2001) and -catenin (Sadot et al., at which time CM was harvested, centrifuged for 10 min at 2,000  g, and
frozen at –80C. Target HEK-293 cells were plated at 105 cells per 6-cm22001), resulting in abrogation of -catenin signaling. For can-
dishes and were grown to confluence. The culture medium was then replacedcers, mutated p53 and/or overexpression of Np63 lead to
with 2 ml CM to be tested. After 24 hr, the cells were collected, and proteininactivation of GSK3, resulting in a probable disassembly of
lysates were analyzed by immunoblotting or immunoprecipitation as de-the APC complex and aberrant intranuclear accumulation of
scribed (Ratovitski et al., 2001). Blots were developed using the enhanced
-catenin (Figure 8B). However, complementary GSK3-inde- chemiluminescence method using Hyperfilm-ECL (Amersham). The films
pendent mechanisms may also play a role in the regulation of were scanned using an UltroScan XL laser densitometer (Pharmacia LKB
Biotechnology).-catenin signaling. Recent observations showed that the p53-
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Transfections, luciferase reporter, and proliferation assays GSK3 protein. For the protein phosphatase assay, following immunoprecip-
itation of total lysates with antibody to PP2A(C), bead-bound proteins wereCells were transiently transfected for 24 hr with plasmids expressing desir-
able proteins using Fugene-6 (Boehringer Mannheim) according to the manu- washed with lysis buffer and then with assay buffer (50 mM Tris [pH 7.0],
0.1 mM CaCl2), resuspended in assay buffer containing 2.5 mM NiCl2 andfacturer’s recommendations.
Transfection efficiency was analyzed by the introduction of pCMV- 900 	g p-nitrophenyl phosphate/ml (Sigma), and incubated for 30 min at
-galactosidase into cells and subsequent measuring of -galactosidase 30C. The amount of p-nitrophenol produced was determined by measuring
activity. In some experiments, we used recombinant adenoviruses (Ad- the absorbance at 405 nm.
Np63, Ad-Np63-AS, or an empty adenovirus, Ad5) to infect target
cells for 18 hr with MOI as indicated (Ratovitski et al., 2001). Cells were Immunofluorescence imaging
resuspended in lysis buffer (50 mM Tris [pH 7.5], 100 mM NaCl, 2 mM EDTA, Cells were than fixed in 3% paraformaldehyde for 2 min at 4C, permealized
0.5% Triton X-100, 0.5% Brij-50, 1 mM PMSF, 0.5 mM NaF, 0.1 mM Na3VO4, with 0.5% Triton X-100 in PBS for 1 min, and blocked with blocking solution
2 complete protease inhibitor cocktail), sonicated for 5 times for 10-s (PBS, 0.1% Tween 20, 5% normal goat serum) for 1 hr at room temperature.
time intervals, and clarified for 30 min at 15,000  g. Supernanatants were Cells were incubated with antibodies to Np63 (1:500) or -catenin (1:100)
resolved by 10% (for APC in 5%) SDS-PAGE and were then analyzed by overnight at 4C. Slides were washed with blocking solution and were incu-
immunoblotting (30–60 	g/lane) or immunoprecipitation (150–200 	g/ bated with FITC-conjugated anti-mouse (or anti-goat) immunoglobulins
lane). (1:1000) and rhodamine-conjugated anti-rabbit (or anti-mouse) immunoglob-
For the luciferase reporter assay, HEK-293 cells grown in 24-well plates ulins (1:1000) for 2 hr in the dark. DNA in nuclei was stained with 4, 6-
were transfected with 0.01 	g LEF-1: luciferase reporter plasmid (wild-type diamino-2-phenylindole (DAPI, 1:10,000) for 5 min. Images were acquired
or mutant) and 0.15 	g -galactosidase plasmid. Various combinations of using the DeltaVision system equipped with a Zeiss Axiovert 100 microscope
plasmids expressing desirable proteins were also introduced into the cells and a Photometrics 300 cooled charge-coupled device camera.
with the total amount not exceeding 1 	g. After 24 hr, transfected cells were
lysed and clarified for 20 min at 15,000  g, and luciferase activities were Acknowledgments
determined. Luminescence was measured using a TD-20e luminometer
(Turner Design) from triplicate plates. The luciferase activities were normal- The plasmids expressing HA-tagged B56, FLAG-tagged GSK3, myc-
ized against the levels of -galactosidase activity. Luciferase activity values tagged-FL--catenin, myc-tagged-N90--catenin, and Lef-1: luciferase re-
obtained from the mutant Lef-1 reporter were subtracted from values ob- porter plasmids (wild-type and mutant) were a kind gift from David M. Virshup
tained from the wild-type Lef-1 reporter and were latter plotted as relative (Huntsman Cancer Institute). We are grateful to Bert Vogelstein (Johns Hop-
fold values compared to control experiment designated as 1. The results kins University School of Medicine) for many reagents and critical comments.
represent data from three independent experiments, and error bars represent We thank L. Lee (Denver Health Medical Center) for CUSP (Np63) cDNA
standard deviations. and S. Ikawa (Institute of Development, Aging and Cancer, Tohoku Univer-
Transfected HNSCC cells were assayed for cell growth using a CellTiter sity) for TAp63 p51B. The C57MG mammary epithelial cells (expressing
96TM AQueous nonradioactive colorimetric proliferative kit according to the Wnt-1) were kindly provided by Anthony M.C. Brown (Cornell University
manufacturer’s recommendations (Promega). A total of 20 	l combined Medical College).
MTS:PMS (20:1) reagent was added to 96-well, cell-free plates (control) and
plates with cells, and plates were incubated for 4 hr at 37C. Plates were
analyzed on plate reader Labsystems Multiscan MCC/340 at A490–A690. Data
obtained from cell-free plates were subtracted from results obtained from Received: January 16, 2002
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References
Subcellular fractionation
Cells were resuspended in buffer A (10 mM KCl, 10 mM Tris [pH 7.9], 1 mM
Bafico, A., Gazit, A., Wu-Morgan, S., Yaniv, A., and Aaronson, S. (1998).
DTT, 250 mM sucrose, 60 	M PMSF with a proteinase inhibitor cocktail) at Characterization of Wnt-1 and Wnt-2 induced growth alterations and signal-
4C, incubated for 20 min on ice with swirling, and lysed by 20 strokes in ing pathways in NIH3T3 fibroblasts. Oncogene 16, 2819–2825.
a Dounce homogenizer. The homogenate was centrifuged at 3000  g for
Barker, N., and Clevers, H. (2000). Catenins. Wnt signaling and cancer.5 min, and the supernatant (cytoplasm) was clarified by centrifugation for
Bioessays 22, 961–965.30 min at 15,000  g. The first pellet (crude nuclei) was resuspended in
5 volumes of buffer A with 0.3% Nonidet P-40, and this suspension was Bradley, R., and Brown, A. (1995). A soluble form of Wnt-1 protein with
mixed with an equal volume of 10 mM Tris (pH 8.0), containing 2.2 M sucrose, mitogenic activity on mammary epithelial cells. Mol. Cell. Biol. 15, 4616–
5 mM magnesium acetate, and 0.1 mM EDTA. Purified nuclei were collected 4622.
by centrifugation through the 2.2 M sucrose cushion. Nuclei were resus-
Chan, E., Gat, U., McNiff, J., and Fuchs, E. (1999). A common human skinpended in buffer B (20 mM HEPES [pH 7.9], 1 mM EDTA, 1 mM EGTA,
tumour is caused by activating mutations in -catenin. Nat. Genet. 21,1 mM DTT, 1 mM PMSF with a proteinase inhibitor cocktail) plus 400 mM
410–413.NaCl and were lysed by vigorous shaking on a Vortex mixer. For subsequent
analysis, nuclear extracts were diluted with buffer B three times. Both nuclear Crook, T., Nichols, J., Brooks, L., O’Nions, J., and Allday, M. (2000). High-
and cytoplasmic fractions were analyzed for purity by immunoblotting with level expression of Np63: a mechanism for the inactivation of p53 in undif-
antibody to DNA topoisomerase II (nuclear marker) and antibody to ferentiated nasopharyngeal carcinoma (NPC)? Oncogene 19, 3439–3444.
-tubulin (cytoplasmic marker).
Dahmen, R., Koch, A., Denkhaus, D., Tonn, J., Sorensen, N., Berthold, F.,
Behrens, J., Birchmeier, W., Wiestler, O., and Pietsch, T. (2001). DeletionsEnzymatic assays
of AXIN1, a component of the WNT/wingless pathway, in sporadic medullo-Following immunoprecipitation of the total lysates with antibody to GSK3,
blastomas. Cancer Res. 61, 7039–7043.the bead-bound proteins were washed in kinase assay buffer (50 mM Tris
[pH 7.5], 10 mM MgCl2, 1 mM dithiotreitol) and were incubated for 30 min de La Coste, A., Romagnolo, B., Billuart, P., Renard, C., Buendia, M., Sou-
at 30C with 5 	Ci [32P]ATP (500–2000 cpm/pmol, Amersham-Pharmacia- brane, O., Fabre, M., Chelly, J., Beldjord, C., Kahn, A., and Perret, C. (1998).
Somatic mutations of the -catenin gene are frequent in mouse and humanBiotech) and a prephosphorylated synthetic peptide (YRRAVPPSPSL
hepatocellular carcinomas. Proc. Natl. Acad. Sci. USA 95, 8847–8851.SRHSSPHQSEDEE) as a substrate for GSK3, as described (Ikeda et al.,
2000). Kinase reaction products were applied to Whatman paper, washed,
Frame, S., and Cohen, P. (2001). GSK3 takes center stage more than 20
and analyzed using a scintillation counter. All assays were performed in years after its discovery. Biochem. J. 359, 1–16.
triplicate. Equivalent aliquots of each GSK3 immunoprecipitate used for
kinase assay were analyzed by immunoblotting to ensure equal amounts of He, T., Sparks, A., Rago, C., Hermeking, H., Zawel, L., da Costa, L., Morin,
378 CANCER CELL : MAY 2002
A R T I C L E
P., Vogelstein, B., and Kinzler, K. (1998). Identification of c-MYC as a target with proliferative potential in normal and neoplastic human keratinocytes. J.
Invest. Dermatol. 113, 1099–1105.of the APC pathway. Science 281, 1509–1512.
Polakis, P. (2000). Wnt signaling and cancer. Genes Dev. 14, 1837–1851.Hibi, K., Trink, B., Patturajan, M., Westra, W., Caballero, O., Hill, D., Ratovit-
ski, E., Jen, J., and Sidransky, D. (2000). AIS is an oncogene amplified in
Ratovitski, E., Patturajan, M., Hibi, K., Trink, B., Yamaguchi, K., and Sidran-
squamous cell carcinoma. Proc. Natl. Acad. Sci. USA 97, 5462–5467.
sky, D. (2001). P53 associates with and targetsNp63 into a protein degrada-
tion pathway. Proc. Natl. Acad. Sci. USA 98, 1817–1822.Ikeda, S., Kishida, S., Yamamoto, H., Murai, H., Koyama, S., and Kikuchi,
A. (1998). Axin, a negative regulator of the Wnt signaling pathway, forms Rubinfeld, R., Albert, I., Porfiri, E., Munemitsu, S., and Polakis, P. (1997).
a complex with GSK-3 and -catenin and promotes GSK3-dependent Loss of beta-catenin regulation by the APC tumor suppressor protein corre-
phosphorylation of -catenin. EMBO J. 17, 1371–1384. lates with loss of structure due to common somatic mutation of the gene.
Cancer Res. 57, 4624–4630.Ikeda, S., Kishida, M., Matsuura, Y., Usui, H., and Kikuchi, A. (2000). GSK3-
dependent phosphorylation of adenomatous polyposis coli gene product Sadot, E., Geiger, B., Oren, M., and Ben-Ze’ev, A. (2001). Down-regulation
can be modulated by -catenin and protein phosphatase 2A complexed of -catenin by activated p53. Mol. Cell. Biol. 21, 6768–6781.
with Axin. Oncogene 19, 537–545.
Satoh, S., Daigo, Y., Furukawa, Y., Kato, T., Miwa, N., Nishiwaki, T., Ka-
Janssens, V., and Goris, J. (2001). Protein phosphatase 2A: a highly regulated wasoe, T., Ishiguro, H., Fujita, M., Tokino, T., et al. (2000). AXIN1 mutations
family of serine/threonine phosphatases implicated in cell growth and signal- in hepatocellular carcinomas, and growth suppression in cancer cells by
ling. Biochem. J. 353, 417–439. virus-mediated transfer of AXIN1. Nat. Genet. 24, 245–250.
Kikuchi, A. (2000). Regulation of -catenin signaling in the Wnt pathway. Salghetti, S., Muratani, M., Wijnen, H., Futcher, B., and Tansey, W. (2000).
Bicohem. Biophys. Res. Commun. 268, 243–248. Functional overlap of sequences that activate transcription and signal ubiqui-
tin-mediated proteolysis. Proc. Natl. Acad. Sci. USA 97, 3118–3123.
Li, X., Yost, H., Virshup, D., and Seeling, J. (2001a). Protein phosphatase
Salghetti, S., Caudy, A., Chenoweth, J., and Tansey, W. (2001). Regulation2A and its B56 regulatory subunit inhibit Wnt signaling in Xenopus. EMBO
of transcriptional activation domain function by ubiquitin. Science 293, 1651–J. 20, 4122–4131.
1653.
Li, Y., Hively, W., and Varmus, H. (2001b). Use of MMTV-Wnt-1 transgenic
Seeling, J., Miller, J., Gil, R., Moon, R., White, R., and Virshup, D. (1999).mice for studying the genetic basis of breast cancer. Oncogene 19, 1002–
Regulation of -catenin signaling by the B56 subunit of protein phosphatase1009.
2A. Science 283, 2089–2091.
Liu, J., Stevens, J., Rote, C., Yost, J., Hu, Y., Neufeld, K., White, R., and
Sparks, A., Morin, P., Vogelstein, B., and Kinzler, K. (1998). Mutational analy-Matsunami, N. (2001). Siah-1 mediates a novel -catenin degradation path-
sis of the APC/-catenin/Tcf pathway in colorectal cancer. Cancer Res. 58,way linking p53 to the adenomatosis poliposis coli protein. Mol. Cell 7,
1130–1134.927–936.
Spink, K., Polakis, P., and Weis, W. (2000). Structural basis of the Axin-Matsuzawa, S., and Reed, J. (2001). Siah-1, SIP, and Ebi collaborate in a
adenomatosis polyposis coli interaction. EMBO J. 19, 2270–2279.
novel pathway for -catenin degradation linked to p53 response. Mol. Cell
7, 915–926. Taipale, J., and Beachy, P. (2001). The Hedgehog and Wnt signalling path-
ways in cancer. Nature 411, 349–354.
McCright, B., Rivers, A., Audlin, S., and Virshup, D. (1996). The B56 family of
Thomas, D., and Tyers, M. (2000). Transcriptional regulation: Kamikaze acti-protein phosphatase 2A (PP2A) regulatory subunits encodes differentiation-
vators. Curr. Biol. 10, R341–R343.induced phosphoproteins that target PP2A to both nucleus and cytoplasm.
J. Biol. Chem. 271, 22081–22089.
van Es, J., Giles, R., and Clevers, H. (2001). The many faces of the tumor
suppressor gene APC. Exp. Cell Res. 264, 126–134.McCright, B., and Virshup, D. (1998). Identifying protein phosphatase 2A
interacting proteins using the yeast two-hybrid method. Methods Mol. Biol. Voeller, H., Truica, C., and Gelmann, E. (1998). -catenin mutations in human
93, 263–277. prostate cancer. Cancer Res. 58, 2520–2523.
Mills, A., Zheng, B., Wang, X., Vogel, H., Roop, D., and Bradley, A. (1999). Yamaguchi, K., Wu, L., Caballero, O., Hibi, K., Trink, B., Resto, V., Cairns,
P63 is a p53 homologue required for limb and epidermal morphogenesis. P., Okami, K., Koch, W., Sidransky, D., and Jen, J. (2000). Frequent gain
Nature 398, 708–713. of the p40/p51/p63 gene locus in primary head and neck squamous cell
carcinoma. Int. J. Cancer 86, 684–689.Morin, P., Sparks, A., Korinek, V., Barker, N., Clevers, H., Vogelstein, B.,
and Kinzler, K. (1997). Activation of -catenin-Tcf signaling in colon cancer Yang, A., Kaghad, M., Wang, Y., Gillett, E., Fleming, M., Dotsch, V., Andrews,
by mutations in -catenin or APC. Science 275, 1787–1790. N., Caput, D., and McKeon, F. (1998). P63, a p53 homolog at 3q27–29,
encodes multiple products with transactivating, death-inducing, and domi-
Nylander, K., Coates, P., and Hall, P. (2000). Characterization of the expres- nant-negative activities. Mol. Cell 2, 305–316.
sion pattern of p63 and Np63 in benign and malignant oral epithelial
Yang, A., Schweitzer, R., Sun, D., Kaghad, M., Walker, N., Bronson, R.,lesions. Int. J. Cancer 87, 368–372.
Tabin, C., Sharpe, A., Caput, D., Crum, C., and McKeon, F. (1999). P63 is
Osada, M., Inaba, R., Shinohara, H., Hagiwara, M., Nakamura, M., and Ikawa, essential for regenerative proliferation in limb, craniofacial and epithelial
Y. (2001). Regulatory domain of protein stability of human P51/TAP63, a development. Nature 398, 714–718.
P53 homologue. Biochem. Biophys. Res. Commun. 283, 1135–1141.
Wong, G., Gavin, B., and McMahon, A. (1994). Differential transformation of
Park, B., Lee, S., Kim, J., Lee, S., Lee, C., Chang, S., Park, J., and Chi, S. mammary epithelial cells by Wnt genes. Mol. Cell. Biol. 14, 6278–6286.
(2000). Frequent alteration of p63 expression in human primary bladder
Zurawel, R., Chiappa, S., Allen, C., and Raffel, C. (1998). Sporadic medullo-carcinomas. Cancer Res. 60, 3370–3374.
blastomas contain oncogenic -catenin mutations. Cancer Res. 58, 896–
899.Parsa, R., Yang, A., McKeon, F., and Green, H. (1999). Association of p63
CANCER CELL : MAY 2002 379
